Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome.
Gianotti
Nicola
N
Soria
Alessandro
A
Galli
Laura
L
Giudici
Barbara
B
Fusetti
Giuliana
G
Lazzarin
Adriano
A
Boeri
Enzo
E
Castagna
Antonella
A
D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D004334:Drug Administration Schedule; D024921:Drug Resistance, Multiple, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D016014:Linear Models; D016896:Treatment Outcome
D017320:HIV Protease Inhibitors